News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Top Considerations for Maintenance Therapy

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

My name is Beth Kramer, and I am 58 years old, and I have faced cancer three times: © stock.adobe.com.

My Three-Time Cancer Journey

January 16th 2026

Image of two men.

Multidisciplinary Care Enhances Lung Cancer Treatment Decisions

ByDr. Graeme M. Rosenberg,Dr. Jorge J. Nieva

January 16th 2026

Dr. Surbhi Sidana

Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma

January 16th 2026

Ronald Chin

Thanks and Gratitude From a Multiple Myeloma Survivor

January 16th 2026

Providing patient-centered education support increases consent rates for genomic testing.

Patient-Centered Support Boosts Genomic Testing Consent in Cancer Care

January 16th 2026

Trending on CURE

Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor

How CAN-3110 Works to Treat Glioblastoma

Cancer Five-Year Survival Rate Hits Record 70%, 2026 Report Shows

HER2 Regimen Nears Two-Year Disease Control in Gastroesophageal Cancer

Tecvayli Associated With Reduced Risk of Myeloma Progression or Death